Cyclic fluctuations in the cardiac performance of the isolated Langendorff-perfused mouse heart: Pyruvate abolishes the fluctuations and has an anti-ischaemic effect

Acta Physiologica Scandinavica

Volumn 175, Issue 4, 2002, Pages 279-287

  Wang, Q D ^b   Tokuno, S ^b   Valen, G ^b   Sjoquist P O ^a   Thoren P ^a,b  

^a ASTRAZENECA R AND D   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Fluctuation; Heart; Perfusion; Pyruvate mouse

Indexed keywords

ANESTHETIC AGENT; BUFFER; GLUCOSE; PYRUVIC ACID; SODIUM; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CRYSTALLOID; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; HEART PROTECTION; ISOLATED HEART; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; CALCIUM; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLES; MAGNESIUM; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; PENTOBARBITAL; PERFUSION; PYRUVIC ACID; SODIUM;

EID: 0036421216     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2002.01003.x     Document Type: Article

References (14)

1. Blank, S., Chen, V., Hamilton, N., Salerno, T. & Ianuzzo, C. 1989. Biochemical characteristics of mammalian myocardia. J Mol Cell Cardiol 21, 367-373.
2. Bünger, R., Haddy, F.J., Querengässer, A. & Gerlach, E. 1975. An isolated guinea pig heart preparation with in vivo ike features. Pflügers Arch Eur J Physiol 353, 317-326.
3. Bünger, R., Mallet, R.T. & Hartman, D.A. 1989. Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Eur J Biochem 180, 221-233.
4. Bünger, R., Swindall, B., Brodie, D., Zdunek, D., Stiegler, H. & Walter, G. 1986. Pyruvate attenuation of hypoxia damage in isolated working guinea pig heart. J Mol Cell Cardiol 18, 423-438.
5. Cavallini, L., Valente, M. & Rigobello, M.P. 1990. The protective action of pyruvate on recovery of ischemic rat heart: Comparison with other oxidizable substrates. J Mol Cell Cardiol 22, 143-154.
6. Deboer, L.W.V., Bekx, P.A., Han, L. & Steinke, L. 1993. Pyruvate enhances recovery of rat hearts after ischemia and reperfusion by preventing free radical generation. Am J Physiol 265, H1571-H1576.
7. Doevendans, P.A., Daemen, M.J., de Muinck, E.D. & Smits, J.S. 1998. Cardiovascular phenotyping in mice. Cardiovasc Res 39, 34-49.
8. Evans, J.R., Opie, L.H. & Renold, A.E. 1963. Pyruvate metabolism in the perfused rat heart. Am J Physiol 205, 971-976.
9. Kameyama, T., Chen, Z., Bell, S.P., Fabian, J. & LeWinter, M. 1998. Mechanoenergetic studies in isolated mouse hearts. Am J Physiol 274, H366-H374.
10. Liedtke, A.J., Neillis, S.H., Neely, J.R. & Hughes, H.C. 1976. Effects of treatment with pyruvate and tromethamine in experimental myocardial ischemia. Circ Res 39, 378-387.
11. Ng, W.A., Grupp, I.L., Subramaniam, A. & Robbins, J. 1991. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res 69, 1742-1750.
12. Opie, L.H. 1998. The Heart: Physiology, from Cell to Circulation, pp. 299-304. Lippincott-Raven, Philadelphia, PA.
13. Regitz, V., Azumi, T., Stephan, H., Naujocks, S. & Schaper, W. 1981. Biochemical mechanism of infarct size reduction by pyruvate. Cardiovasc Res 15, 652-658.
14. Trost, S.U., Omens, J.H., Karlon, W.J. et al. 1998. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heart shock protein 70. J Clin Invest 101, 855-862.